Lilly's Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight loss
Impressions47.1K
HealthIn D2TR
#47 in Health among publishers in Google Discover in Brazil over the last 30 days.
Most of its Discover visibility comes from publications tied to scheduled events.
Rank and share come from the D2TR publisher ranking and are rebuilt every 7 days. Impressions are shown for the last 14 days. Estimates, not Google data. D2TR is not affiliated with Google or with Eli Lilly.